Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Meclizine is a histamine H1 antagonist used to treat nausea, vomiting, and dizziness associated with motion sickness. It is used in the symptomatic treatment of motion sickness and control of vertigo associated with vestibular system diseases.
- Mechanism
- Curator reviewed · 3 references
Vomiting is a centrally regulated reflex mechanism that initiates from the vomiting center and the chemoreceptor trigger zone (CTZ) located in the medulla. Motion sickness is also regulated by CTZ. The blood-brain barrier near the CTZ is relatively permeable to circulating mediators and CTZ can transmit impulses to vomiting center located in the brainstem. Different receptors responding to different factors, including histamine, 5-HT, enkephalins, substance P, and dopamine, are expressed along the brainstem to activate respective pathways and contribute to the control of vomiting. Histamine H1 receptors are expressed on the vestibular nuclei and nucleus of the solitary tract (NTS) that are activated by motion sickness and stimuli from the pharynx and stomach. When activated, H1 receptor signaling from these nuclei is transmitted to the CTZ and vomiting centre.
Through its antagonistic action on the H1 receptors, meclizine primarily works by inhibiting signaling pathway transduction through histaminergic neurotransmission from the vestibular nuclei and NTS to the CTZ and medullary vomiting center. Meclizine may also decrease the labyrinth excitability and vestibular stimulation.
- Primary indication
- Indicated for the symptomatic treatment of nausea, vomiting, and dizziness associated with motion sickness, and management of vertigo due to various causes, including radiation sickness, Meniere’s syndrome, labyrinthitis and other vestibular disturbances.Curator reviewed · 3 structured indications
- Formula / weight
- C25H27ClN2 · 390.948 g/mol (avg)
- First approval
- Canada, 2007 · United States, 1981
- Also known as
- Meclozine
- Code names
- UCB 170 · U.C.B. 5062
- Brand names
- Antivert
- Bonine
- Diphen
- Dramamine
- Travel-ease
Resolves to
OCJYIGYOJCODJL-UHFFFAOYSA-NSMILESCC1=CC(CN2CCN(CC2)C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)=CC=C1What you can answer from here — as of September 26, 2026
Which drugs share a target with Meclizine, and which of those have an active Phase 3 trial?